Back to Industry News
Medtech
Fractyl Health says experimental procedure helps maintain weight loss in study
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Reuters
Photo by Total Shape on Unsplash
Stay updated on stories like this
Key takeaways
- Fractyl Health's stock surged 15% following the release of study data indicating that its investigational outpatient procedure may help maintain weight loss after patients discontinue GLP-1 receptor agonist medications
- The company reported positive results suggesting the procedure could mitigate weight regain typically associated with ceasing GLP-1 drug therapy
Fractyl Health's stock surged 15% following the release of study data indicating that its investigational outpatient procedure may help maintain weight loss after patients discontinue GLP-1 receptor agonist medications. The company reported positive results suggesting the procedure could mitigate weight regain typically associated with ceasing GLP-1 drug therapy.
Never miss stories like this